Tharimmune, Inc.
THARNASDAQ
Healthcare
Biotechnology
$3.29
+0.21(6.8%)
52W $1.05 – $7.71
Quick:
10-K
Mar 31, 2026 (6 days ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Mar 31, 2026 (6 days ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 3, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 3, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 18, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Feb 6, 2026 (1 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 6, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Feb 3, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G
Feb 2, 2026 (2 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 2, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 26, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 22, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jan 21, 2026 (2 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jan 20, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 15, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Dec 12, 2025 (3 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 7, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 6, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction